The European Medicines Agency Review of Gilteritinib (Xospata) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an FLT3 Mutation
欧洲药品管理局对吉瑞替尼（Xospata）用于治疗伴有FLT3突变的复发或难治性急性髓系白血病成人患者的审查
期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2019-0976
Tzogani, Kyriaki; Røshol, Hilde; Olsen, Helga Haugom; Aas, Ida B; Dalhus, Marianne Løiten; Håkonsen, Gro Dahlseng; Nilssen, Laila Sortvik; Lindberg, Vibeke; Økvist, Mats; Bolstad, Bjørg; Rogovska, Irēna; Karpova, Natalja; Enzmann, Harald; Gisselbrecht, Christian; Pignatti, Francesco
